跳转至内容
Merck
CN

94517

喹啉

analytical standard

别名:

1-偶氮萘, 苯并吡啶

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C9H7N
化学文摘社编号:
91-22-5
分子量:
129.16
UNSPSC Code:
85151701
NACRES:
NA.24
PubChem Substance ID:
329770348
EC Number:
202-051-6
Beilstein/REAXYS Number:
107477
MDL number:
MFCD00006736

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

喹啉, analytical standard

InChI key

SMWDFEZZVXVKRB-UHFFFAOYSA-N

InChI

1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H

SMILES string

c1ccc2ncccc2c1

grade

analytical standard

vapor density

4.5 (vs air)

vapor pressure

0.07 mmHg ( 20 °C)

assay

≥98.0% (GC)
97.5-102.2% (wt., NT)

autoignition temp.

896 °F

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

refractive index

n20/D 1.625 (lit.)

bp

113-114 °C/11 mmHg (lit.)
237 °C (lit.)

mp

−17-−13 °C (lit.)

density

1.093 g/mL at 25 °C (lit.)

application(s)

cleaning products
cosmetics
flavors and fragrances
food and beverages
personal care

format

neat

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

有关合适的仪器技术的更多信息，请参阅产品的分析证书。想要获得更多支持，请联系技术服务部。

Other Notes

在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Aquatic Chronic 2 - Carc. 1B - Eye Irrit. 2 - Muta. 2 - Skin Irrit. 2

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 2

flash_point_f

213.8 °F - closed cup

flash_point_c

101 °C - closed cup

法规信息

危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL9303
BCCG1563
BCBX3571
BCBT7647

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

R Musiol et al.
Current medicinal chemistry, 17(18), 1960-1973 (2010-04-10)
Although the assortment of antifungal drugs is broad, the most commonly used agents have major drawbacks. Toxicity, serious side effects or the emergence of drug resistance are amongst them. New drugs and drug candidates under clinical trials do not guarantee
Paul D Roepe
Future microbiology, 4(4), 441-455 (2009-05-07)
30 years before the discovery of the pfcrt gene, altered cellular drug accumulation in drug-resistant malarial parasites had been well documented. Heme released from catabolized hemoglobin was thought to be a key target for quinoline drugs, and additional modifications to
Alexander P Gorka et al.
Journal of medicinal chemistry, 56(13), 5231-5246 (2013-04-17)
Historically, the most successful molecular target for antimalarial drugs has been heme biomineralization within the malarial parasite digestive vacuole. Heme released from catabolized host red blood cell hemoglobin is toxic, so malarial parasites crystallize heme to nontoxic hemozoin. For years
Chunrong Wang et al.
Bioscience, biotechnology, and biochemistry, 79(1), 164-170 (2014-09-02)
A novel quinoline-degrading strain, named K4, was isolated from activated sludge of a coking wastewater treatment plant and identified as Brevundimonas sp. on the basis of its 16s rDNA gene sequence analysis. Its optimum temperature and pH for quinoline degradation
Mohanad Darawsheh et al.
European journal of medicinal chemistry, 82, 152-163 (2014-06-07)
Starting from the precursor [Zinc Valproate complex] (1), new mixed ligand zinc(II) complexes of valproic acid and nitrogen-based ligands, formulating as, [Zn(valp)22,9-dmphen] (2), [Zn2(valp)4(quin)2] (3), [Zn(valp)2(2-ampy)2] (4), and [Zn(valp)2(2-ampic)2] (5) (valp = valproate, 2,9-dmphen = 2,9-dimethyl-1,10-phenanthroline, quin = quinoline, 2-ampy
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持